Vertex Pharmaceuticals Ownership | Who Owns Vertex Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Vertex Pharmaceuticals Ownership Summary


Vertex Pharmaceuticals is owned by 23.21% institutional investors, 0.15% insiders, and 76.64% retail investors. Capital world investors is the largest institutional shareholder, holding 10.09% of VRTX shares. American Funds Growth Fund of Amer A is the top mutual fund, with 4.72% of its assets in Vertex Pharmaceuticals shares.

VRTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVertex Pharmaceuticals23.21%0.15%76.64%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Capital world investors25.91M10.09%$10.15B
Vanguard group24.22M9.43%$9.48B
Blackrock funding, inc. /de22.25M8.67%$8.72B
Blackrock21.31M8.25%$9.99B
Capital research global investors16.55M6.45%$6.48B
State street11.61M4.52%$4.55B
Jpmorgan chase6.43M2.51%$2.52B
Geode capital management5.97M2.33%$2.33B
Wellington management group llp4.77M1.86%$1.87B
Capital investors4.69M1.83%$1.84B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Kynam capital management, lp330.00K11.93%$154.68M
Provident investment management155.07K5.96%$62.45M
Montchanin asset management10.74K4.76%$5.03M
Bellevue group505.81K4.12%$198.09M
Bridger management18.78K3.96%$7.35M
Artia global partners lp55.10K3.42%$21.58M
Healthinvest partners ab17.77K2.74%$738.67K
Mcrae capital management33.16K2.58%$12.99M
Birch hill investment advisors153.60K2.54%$60.16M
Sofinnova investments117.88K2.52%$46.16M

Top Buyers

HolderShares% AssetsChange
Norges bank3.41M0.18%3.41M
Capital investors4.69M0.30%2.05M
Clearbridge investments2.65M0.78%1.12M
Jpmorgan chase6.43M0.15%565.42K
Assenagon asset management763.70K0.41%520.95K

Top Sellers

HolderShares% AssetsChange
Fmr3.30M0.07%-3.10M
Capital world investors25.91M1.39%-2.82M
Jennison associates3.45M0.79%-2.70M
Edgewood management1.49M2.06%-967.40K
Massachusetts financial services co /ma/503.16K0.06%-781.19K

New Positions

HolderShares% AssetsChangeValue
Norges bank3.41M0.18%3.41M$1.37B
Rakuten investment management242.46K0.09%242.46K$24.14M
Axa investment managers163.68K0.17%163.68K$64.10M
Sofinnova investments117.88K2.52%117.88K$46.16M
Freestone grove partners lp110.28K0.32%110.28K$43.19M

Sold Out

HolderChange
Perkins coie trust-1.00
Mcclarren financial advisors-1.00
Ruedi wealth management-1.00
Mine & arao wealth creation & management, llc.-1.00
Tfo-tdc-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025865-46.24%59,581,660-75.23%230.26%362-50.82%356-41.54%
Jun 30, 20251,575-5.06%240,147,0121.70%931.11%716-14.86%5994.90%
Mar 31, 20251,6401.74%235,693,425-0.06%911.09%82911.42%567-7.35%
Dec 31, 20241,444-9.69%218,148,736-5.74%841.05%664-9.78%543-5.89%
Sep 30, 20241,575-1.25%231,077,223-1.65%891.08%726-11.68%56810.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds Growth Fund of Amer A12.13M4.72%790.12K
Capital Group Growth Fnd of Amer Comp12.13M4.72%790.12K
Vanguard US Total Market Shares ETF8.18M3.19%16.09K
Vanguard Total Stock Mkt Idx Inv8.07M3.15%-186.29K
Vanguard Institutional 500 Index Trust7.30M2.84%51.91K
Vanguard 500 Index Investor6.36M2.48%-931.08K
Invesco QQQ Trust5.29M2.06%36.76K
American Funds American Balanced A4.93M1.92%-
Capital Group New Perspective Comp4.56M1.78%538.65K
American Funds New Perspective A4.56M1.78%538.65K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 03, 2025WAGNER CHARLES F JR EVP, CO & FOSell$3.23M
Dec 03, 2025WAGNER CHARLES F JR EVP, CO & FOSell$3.16M
Dec 03, 2025Tatsis Ourania EVP, Chief Reg. & Quality Off.Sell$2.02M
Dec 03, 2025LEIDEN JEFFREY M Executive ChairmanSell$1.97M
Dec 03, 2025LEIDEN JEFFREY M Executive ChairmanSell$582.46K

Insider Transactions Trends


DateBuySell
2025 Q4-23
2025 Q341
2025 Q2-2
2025 Q1-21
2024 Q4-4

VRTX Ownership FAQ


Who Owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals shareholders are primarily institutional investors at 23.21%, followed by 0.15% insiders and 76.64% retail investors. The average institutional ownership in Vertex Pharmaceuticals's industry, Biotech Stocks , is 45.22%, which Vertex Pharmaceuticals falls below.

Who owns the most shares of Vertex Pharmaceuticals?

Vertex Pharmaceuticals’s largest shareholders are Capital world investors (25.91M shares, 10.09%), Vanguard group (24.22M shares, 9.43%), and Blackrock funding, inc. /de (22.25M shares, 8.67%). Together, they hold 28.20% of Vertex Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vertex Pharmaceuticals?

Yes, BlackRock owns 8.25% of Vertex Pharmaceuticals, totaling 21.31M shares as of Jun 2024. This represents 0.23% of BlackRock's total assets, with a market value of 9.99B$. In the last quarter, BlackRock decreased its holdings by -648K shares, a -2.95% change.

Who is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Kynam capital management, lp is Vertex Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 11.93% of its assets in 330K Vertex Pharmaceuticals shares, valued at 154.68M$.

Who is the top mutual fund holder of Vertex Pharmaceuticals shares?

American Funds Growth Fund of Amer A is the top mutual fund holder of Vertex Pharmaceuticals shares, with 4.72% of its total shares outstanding invested in 12.13M Vertex Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools